|
Delayed
OTC Markets
19:43:10 06/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.000001 USD | 0.00% |
|
0.00% | -99.80% |
| Market Cap | 1.3M 1.12M 1.05M 962K 1.81M 124M 1.82M 12.49M 4.86M 62.9M 4.89M 4.79M 208M | P/E 2023 |
-2.13x | P/E 2024 | -2.52x |
|---|---|---|---|---|---|
| Enterprise Value | 7.55M 6.5M 6.1M 5.57M 10.47M 718M 10.54M 72.34M 28.15M 364M 28.35M 27.74M 1.21B | EV / Sales 2023 |
394,366,816x | EV / Sales 2024 | 171,944,593x |
| Free-Float |
100% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 month | 0 | 0 | |
| Current year | 0 | 0.01 | |
| 1 year | 0 | 0.01 | |
| 3 years | 0 | 0.25 | |
| 5 years | 0 | 2.15 | |
| 10 years | 0 | 4.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | - | |
Radka Milanova
CTO | Chief Tech/Sci/R&D Officer | 71 | - |
James Smeeding
PRN | Corporate Officer/Principal | - | 01/05/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
James Smeeding
BRD | Director/Board Member | - | 01/05/2020 |
Abdul Nnyenje
BRD | Director/Board Member | - | 20/10/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/04/23 | Buy | Director | 80,000 | 0.0824% | ||
| 22/09/20 | Buy | Chief Executive Officer | 10,000 | 0.0118% | ||
| 22/09/20 | Other | Chief Executive Officer | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | - | - | 117 | ||
| -0.89% | -0.89% | +9.71% | -11.13% | 2.56B | ||
| -2.24% | +3.95% | +41.05% | +103.51% | 2.28B | ||
| -0.61% | -2.66% | -43.18% | +62.89% | 518M | ||
| +1.85% | -5.17% | -10.57% | +37.50% | 60.48M | ||
| Average | -0.45% | -0.41% | -0.75% | +48.19% | 1.08B | |
| Weighted average by Cap. | -1.54% | +1.58% | +17.59% | +44.65% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 0.07 0.06 0.06 0.05 0.1 6.86 0.1 0.69 0.27 3.48 0.27 0.26 11.52 | 0.1 0.08 0.08 0.07 0.13 9.15 0.13 0.92 0.36 4.64 0.36 0.35 15.37 |
| Net income | -10.68M -9.19M -8.63M -7.88M -14.8M -1.02B -14.91M -102M -39.79M -515M -40.08M -39.21M -1.71B | -3.98M -3.42M -3.21M -2.93M -5.51M -378M -5.55M -38.09M -14.82M -192M -14.93M -14.6M -635M |
| Net Debt | 5.65M 4.87M 4.57M 4.17M 7.84M 538M 7.89M 54.14M 21.07M 273M 21.22M 20.76M 903M | 6.25M 5.38M 5.05M 4.61M 8.66M 594M 8.72M 59.85M 23.29M 301M 23.46M 22.95M 998M |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- ALID Stock
Select your edition
All financial news and data tailored to specific country editions
















